Investment Rating - The investment rating for the company is "Buy" [7] Core Views - The recent decline in the company's stock price has already factored in the impairment impact and the market liquidity contraction [1] - The company plans to distribute a final dividend of HKD 0.13 per share for the fiscal year 2025, resulting in a total annual dividend of HKD 0.25 per share, maintaining a dividend payout ratio of 70.2% [1] - The acquisition of Shandong Qinbin Expressway is expected to contribute positively to earnings starting in 2026 [1] Revenue and Profitability - The company reported a revenue of HKD 4.33 billion for the fiscal year 2025, representing a year-on-year increase of 12.0% [11] - The net profit attributable to the parent company was HKD 533 million, a decrease of 18.9% year-on-year [11] - Excluding impairment factors, the company's net profit excluding non-recurring items grew by 8.4% year-on-year to HKD 712 million [1][11] Traffic Revenue Growth - The company's toll revenue increased by 12.2% year-on-year in fiscal year 2025, primarily due to the acquisition of Pinglin Expressway [2] - The Han-Ehu Expressway saw a toll revenue increase of 22% year-on-year, benefiting from the closure and expansion of the Wuhuang Expressway [2] Cost and Margin Analysis - Operating costs increased by 19.6% year-on-year, while gross profit grew by 3.6% [3] - The company adjusted its intangible asset amortization, leading to a rise in costs [3] - Financial expenses decreased by 10.7% year-on-year due to lower market interest rates [3] Acquisition Impact - The acquisition of 85% of Shandong Qinbin Expressway for HKD 1.153 billion is expected to yield an estimated internal rate of return (IRR) of approximately 10.43% [4] - The projected net profits from Qinbin Expressway for 2026 to 2028 are estimated at HKD 124 million, HKD 162 million, and HKD 195 million respectively [4] Earnings Forecast and Valuation - The forecast for net profit attributable to the parent company for 2026 and 2027 has been adjusted to HKD 818 million and HKD 801 million, respectively [5] - The target price has been raised to HKD 5.53 based on a 10x 2026E PE ratio [5] - The estimated dividend yield for 2026 is projected to be 7.8%, indicating strong attractiveness [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][9]. Core Insights - The company has demonstrated strong revenue growth driven by AI-enhanced imaging and design products, with a year-over-year increase of 41.6% in this segment. The overall revenue for 2025 reached 3.86 billion RMB, reflecting a year-over-year growth of 28.8% [4][6]. - The adjusted net profit for the company saw a significant increase of 64.7% year-over-year, amounting to 970 million RMB, indicating improved profitability largely due to the leverage from high-margin AI-driven products [4][6]. - The AI Agent strategy has been pivotal in driving user growth and accelerating commercialization, with the monthly active users (MAU) reaching 276 million by December 2025, a 3.8% increase year-over-year [6][9]. Financial Performance - For 2025, the company reported a gross profit of 2.84 billion RMB, with a gross margin of 73.6%, which is a slight decrease of 2.4 percentage points year-over-year [4][6]. - The forecast for revenue growth is robust, with expected revenues of 4.86 billion RMB in 2026, 5.86 billion RMB in 2027, and 6.95 billion RMB in 2028, reflecting growth rates of 26%, 21%, and 19% respectively [8][9]. - The adjusted net profit is projected to reach 1.30 billion RMB in 2026, 1.71 billion RMB in 2027, and 2.13 billion RMB in 2028, with growth rates of 34%, 32%, and 24% respectively [8][9]. User Engagement and Product Development - The company has successfully increased its paid subscription user base to 16.91 million, a 34.1% increase year-over-year, with a subscription penetration rate of 6.1%, up by 1.4 percentage points [6][9]. - The AI Agent functionality has significantly enhanced user engagement, particularly in productivity tools, which saw a 67.4% increase in paid subscribers, indicating a strong demand for high-value creative solutions [6][9]. - The integration of AI capabilities into the company's product offerings has improved content creation efficiency and quality, positioning the company favorably in the competitive landscape [6][9].

[Table_Info1] [Table_Title] 证券研究报告 / 港股公司报告 国内案例数高增，海外大幅减亏，前景持续向好 ---时代天使年报业绩点评 事件： [Table_Summary] 公司发布业绩预告，2025 财年实现营收 370.28 百万美元（+37.8%），实 现净利润 26.33 百万美元（+162.8%），业绩表现超预期。 点评： 经营端：巧用价格工具，实现国内案例数量增大于价减。海外市场维持 高增，26 年有望实现海外市场闭环布局。1）25 年国内达成案例数 27.62 万例（+26.3%），占比 51.9%，主要系公司为应对竞品降价竞争，采用跟 随价格策略维持市场地位，实现案例数同比大幅增，规模效应进一步释 放；2）25 年海外达成案例数 25.62 万例（+82.1%），保持高速增长。① 海外团队拓展与区域开发协同并进，巴西、东南亚设计中心完成团队建 设并投产；②美国工厂预期 26 年内小批量投产，海外年内有望初步形成 设计-生产-交付闭环布局，海外竞争壁垒持续加强。 利润端：国内外市场业绩表现优异，海外市场盈利可期。1）国内市场： 实现营收 2.07 亿美元（+10.1%） ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][10] Core Insights - The company reported a revenue of 5.764 billion RMB for 2025, representing a year-over-year increase of 15.0%, and an adjusted net profit of 1.629 billion RMB, which is an 85.7% increase year-over-year [6][8] - The gaming business is expected to continue its growth, driven by multiple successful products and improvements in advertising algorithms on the TapTap platform [7][8] - The company anticipates significant revenue and profit growth from its core games and the expansion of the TapTap ecosystem, projecting revenues of 7.090 billion RMB, 8.260 billion RMB, and 9.440 billion RMB for 2026, 2027, and 2028 respectively [8][9] Summary by Sections Recent Performance - The company's stock performance over the last 12 months shows an increase of 89.2%, outperforming the Hang Seng Index, which increased by 7.2% [5] - The current stock price is 60.45 HKD, with a market capitalization of approximately 29.888 billion HKD [5] Financial Forecast - The company forecasts revenues of 7.090 billion RMB for 2026, with a growth rate of 23%, and net profits of 2.101 billion RMB, reflecting a growth rate of 37% [9][10] - The projected P/E ratios for the next three years are 12.5, 10.5, and 8.7 respectively [9][10] Business Drivers - The gaming segment is bolstered by successful titles such as "Ragnarok M: Beginners," "Heart Town," and "Torchlight: Infinite," which collectively contributed to a 10.5% increase in gaming revenue [7] - The TapTap platform's revenue grew by 24.7% due to enhancements in advertising algorithms and increased user engagement [7]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company has shown impressive performance in 2025, driven by both store expansion and growth in same-store sales [5] - The company achieved a revenue of 12.91 billion RMB in 2025, representing a year-on-year growth of 46.9% [7] - The net profit attributable to shareholders reached 3.11 billion RMB in 2025, with a remarkable year-on-year increase of 110.3% [7] - The company continues to expand its store network, with a total of 13,554 stores as of December 31, 2025, marking a 36.7% increase year-on-year [7] - The average daily GMV per store increased by 20% to 7,800 RMB in 2025 [7] - The company is expected to maintain strong growth in net profit for 2026-2028, with projections of 3.43 billion RMB, 4.15 billion RMB, and 4.77 billion RMB respectively [8] Financial Summary - Revenue projections for 2026 are estimated at 16.15 billion RMB, with a year-on-year growth rate of 25.1% [6] - The projected net profit for 2026 is 3.43 billion RMB, reflecting a growth rate of 10.2% [6] - The company’s P/E ratio is projected to decrease from 17.92 in 2025 to 11.98 in 2028, indicating improving valuation [6] - The company maintains a high return on equity (ROE) of 71.6% in 2024, which is expected to decline gradually to 39.7% by 2028 [6]

Investment Rating - The investment rating for the company is "Outperform the Market" [6][28]. Core Insights - The company achieved a total revenue of 3.86 billion HKD in 2025, representing a year-on-year growth of 29%, with adjusted profit increasing by 65% [2][11]. - The paid penetration rate reached 6.1%, up by 1.4 percentage points year-on-year, driven by strong growth in image design product revenue [4][15]. - The company has integrated AI capabilities into its product matrix, enhancing its offerings and driving revenue growth [5][16]. Financial Performance - Total revenue for 2025 was 3.86 billion HKD, with image product revenue growing significantly [2][11]. - The gross profit was 2.84 billion HKD, with a gross margin of 74%, a slight decrease of 2 percentage points year-on-year [3][12]. - Adjusted net profit for 2025 was 965 million HKD, with an adjusted net profit margin of 25%, an increase of 5 percentage points year-on-year [3][12]. Business Segments - Revenue from image and design products accounted for 74% of total revenue, while advertising revenue constituted 22% [2][11]. - The company terminated its cosmetics supply chain management service in November 2025, reclassifying its AI skin testing business [2][11]. User Metrics - Monthly active users (MAU) reached 276 million, a 4% increase year-on-year, while paid members grew to 16.91 million, a 34% increase [4][15]. - The average revenue per paying user (ARRPU) was estimated at 200 HKD, reflecting a 4% year-on-year increase [4][15]. AI Integration - The company launched the AI-native platform RoboNeo in July 2025, which integrates various AI functionalities into its products [5][16]. - The AI agent capabilities have become a significant driver of revenue growth, particularly in the company's design studio [5][16]. Future Outlook - The company is expected to maintain strong growth in adjusted net profit, with projections of 1.35 billion HKD, 1.70 billion HKD, and 2.05 billion HKD for 2026, 2027, and 2028, respectively [20].

Investment Rating - The report assigns a "BUY" rating for the company, indicating a potential upside in the stock price [5]. Core Insights - The company is expected to benefit from the recovery of the Hainan market, with a projected net profit of RMB 49 billion, RMB 54.6 billion, and RMB 63.5 billion for the years 2026, 2027, and 2028 respectively, reflecting year-on-year growth rates of 36.5%, 11.6%, and 16.2% [6][8]. - The company's performance in the fourth quarter of 2025 showed a revenue increase of 2.8% year-on-year, with a net profit growth of 53.6% [6][8]. - The report highlights the resilience of the duty-free business, with duty-free revenue reaching RMB 391.6 billion in 2025, a year-on-year increase of 1% [8]. Summary by Relevant Sections Company Overview - The company operates in the retail trade sector, with a current H-share price of RMB 64.95 and a market capitalization of RMB 134.95 billion [2]. - The stock has experienced a 12-month high of RMB 106.6 and a low of RMB 42.48, with a year-to-date price change of -11.15% [2]. Financial Performance - For the year 2025, the company reported a revenue of RMB 53.7 billion, a decrease of 4.9% year-on-year, and a net profit of approximately RMB 3.6 billion, down 16% year-on-year [6]. - The gross margin for the year increased by 0.72 percentage points to 33%, driven by reduced discounting in Q4 [8]. Future Outlook - The company anticipates continued growth in the Hainan duty-free market, with sales in January and February 2026 reaching RMB 10.59 billion, a year-on-year increase of 25.9% [8]. - The expected earnings per share (EPS) for 2026, 2027, and 2028 are projected to be RMB 2.37, RMB 2.64, and RMB 3.07 respectively, with corresponding price-to-earnings (P/E) ratios of 24, 22, and 19 [10][12].

Investment Rating - The report maintains a "Buy" rating for the company, Hansoh Pharmaceutical (3692 HK), with a target price adjusted to HKD 44.50, indicating a potential upside of 25.4% from the current closing price of HKD 35.48 [1][6][10]. Core Insights - The company exceeded expectations in its 2025 performance, with innovative drugs contributing nearly 70% to product sales revenue. The collaboration income has also normalized, enhancing overall performance. The mid-to-late stage pipeline is rich and progressing rapidly, with a new wave of product launches expected starting in 2027, providing greater visibility for long-term growth [2][6]. - The company reported a year-on-year revenue growth of 23% and a net profit growth of 27% for 2025, reaching RMB 15.03 billion and RMB 5.56 billion, respectively. Product sales revenue increased by 20.8%, with innovative drug revenue rising by 30%, accounting for 68% of total sales [6][11]. - The report highlights the efficient advancement of the innovative pipeline, with several key products expected to enter critical phases in 2026. Notable products include HS-20093, HS-20089, HS-20094, and HS-10374, with multiple products set to initiate Phase III or key registration clinical trials this year [6][11]. Financial Performance - The financial forecast for 2026 estimates revenue of RMB 16.81 billion, with a projected EBIT of RMB 5.25 billion. The net profit is expected to be RMB 5.02 billion, reflecting a decrease from 2025 due to increased R&D expenses [11][12]. - The company plans to increase R&D investment by over 30% in 2026, with a continued focus on innovative drug development and market expansion [6][11]. - The report indicates a stable growth trajectory for the company's flagship product, Ameluz, with sales expected to maintain a peak of RMB 8 billion before 2030 [6].

Investment Rating - The report maintains a "Buy" rating for Yadea Holdings (01585.HK) [1] Core Views - The company achieved record high revenue and profit in 2025, with total revenue reaching RMB 37.01 billion, a year-on-year increase of 31.1%, and net profit attributable to shareholders of RMB 2.91 billion, up 128.8% [1][4] - The sales volume reached a historical high of 16.27 million units, reflecting a 25% year-on-year growth, with the average retail price increasing to RMB 2,275 [2] - The company is accelerating its international expansion in Southeast Asia, leveraging regional growth opportunities and supply chain investments, although the overseas business is currently in an investment phase and not yet profitable [2][3] Financial Performance - The gross margin improved to 19.1%, an increase of 3.9 percentage points year-on-year, driven by product premiumization and cost optimization [2] - The net profit margin reached 7.9%, up 3.4 percentage points year-on-year, with total expenses as a percentage of revenue decreasing to 11.2% [2] - Forecasted net profits for 2026-2028 are expected to be RMB 3.32 billion, RMB 3.86 billion, and RMB 4.11 billion, representing growth rates of 14%, 16%, and 6% respectively [4][7] Product and Market Strategy - The company is focusing on high-end product offerings, with over 57.4% of retail sales coming from products priced above RMB 3,000 [2] - New product lines, including sodium-ion batteries and a new brand targeting the mid-to-high-end market, are set to launch, with significant growth potential in the three-wheeled vehicle segment [3] - The company plans to sell approximately 1 million sodium-ion battery units in 2026, indicating a strong commitment to innovation and market expansion [3]

Investment Rating - The report maintains a "Buy" rating for Yadea Holdings (1585 HK) with a target price of HKD 22.63, indicating a potential upside of 70.8% from the current price of HKD 13.25 [1][2][8]. Core Insights - The company's profitability is driven by a high-end product strategy and accelerated overseas business development. The report highlights a strong recovery in two-wheeler sales in 2025, with a projected year-on-year growth of 25% to 16.27 million units, returning to 2023 levels. Revenue for 2025 is expected to reach RMB 37.01 billion, a 31.1% increase, with net profit soaring by 128.8% to RMB 2.912 billion [6][12]. - The report anticipates a slight sales pressure in the first half of 2026 due to the transition to new national standards, but expects a 6% year-on-year growth in sales for the year overall, with better performance in the second half [6][12]. - The company is focusing on improving its product mix and enhancing gross margins through high-end product offerings, with the average selling price (ASP) for electric bicycles and scooters increasing by 5% and 4% respectively in 2025 [6][12]. - The overseas business is projected to grow, with two-wheeler sales reaching 300,000 units in 2025, accounting for 2% of total sales. The report notes that rising oil prices due to geopolitical uncertainties may accelerate the shift from fuel motorcycles to electric two-wheelers in Southeast Asia [6][12]. Financial Summary - Revenue projections for Yadea Holdings are as follows: - 2024: RMB 28.236 billion - 2025: RMB 37.008 billion - 2026E: RMB 42.049 billion - 2027E: RMB 46.851 billion - 2028E: RMB 52.104 billion - Net profit projections are: - 2024: RMB 1.272 billion - 2025: RMB 3.109 billion - 2026E: RMB 3.482 billion - 2027E: RMB 3.991 billion - 2028E: RMB 4.644 billion [5][12][13]. - The report indicates a projected gross margin improvement to 19.4% in 2026, with a net profit margin of 8.3% [7][12].